Search

everythinglearnresearchcommunity

for

Search:↓

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Antibiotics can reduce acne but may lead to resistant bacteria, and understanding the skin's bacteria is important for treatment.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Plant compounds may offer a promising alternative for cancer treatment.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

Different techniques for vitiligo treatment work similarly well, with some better for specific body areas.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Polyesters show promise for repairing damaged blood vessels.